News, 11 November 2002
A row has erupted among doctors at an English hospital over plans to
abort a twin boy in the final weeks of pregnancy. A consultant at the
Royal Victoria Infirmary in Newcastle first proposed aborting the twin
a month ago after the child was diagnosed with a heart defect which he
considered to be inoperable. However, the child's 19-year-old mother is
now into her 35th week of pregnancy and other consultants and
specialists at the hospital believe that the abortion would have
disastrous psychological effects. Medical opinion is also divided as to
the child's prognosis, with several experts believing that he has a
good chance of leading a normal life. One doctor has now threatened the
hospital's medical director with legal action if the late-term abortion
is allowed to proceed, although the latest reports suggest that the
mother has now refused the abortion. Late-term abortions up to birth
are allowed in Britain when doctors believe that the victim would be
born "seriously handicapped". In this case the abortion would be
performed by injecting potassium chloride directly into the child's
heart, and his dead body would then be delivered at the same time as
his living twin sister. [Sunday Times, 10 November; The Journal, 11
November]
A South Korean bishop has warned that "the culture of death will
dull the conscience of Catholics" if priests fail to speak out against
abortion. In a pastoral letter, Bishop Boniface Choi-Ki-san of Inchon
wrote: "Abortion is a particularly heinous form of murder because it
kills an innocent child who cannot defend himself in his mother's womb,
which should be the safest place in the world." South Korea's abortion
rate is one of the highest in the world. There are nearly two million
abortions each year, and abortions outnumber live births by three to
one. [
Zenit, 8 November]
The council of the Ontario College of Pharmacists has voted unanimously
to propose a change in the law to allow them to provide abortifacient
morning-after pills without a doctor's prescription. A 16-month trial
scheme in which 40 pharmacies in Toronto have been able to dispense the
morning-after pill is due to end within two weeks, and an amendment to
the state's Drug and Pharmacy Regulations Act is needed to allow the
scheme to continue. However, Ontario's health minister has insisted
that no decision will be made on changing the law until after data from
the trial project is received in June. 7,000 women have received the
morning-after pill from pharmacists over the course of the trial. [The
Toronto Star, 8 November; via Pro-Life E-News]
To subscribe to SPUC's email information services, please visit www.spuc.org.uk/em-signup. The reliability of the news herein is dependent on that of the cited sources, which are paraphrased rather than quoted. Opinions expressed are not necessarily those of the society. © Society for the Protection of Unborn Children, 2012